المؤلفون: Drögemöller BI; Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Canada; Faculty of Pharmaceutical Sciences, University of British Columbia, Canada; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada., Wright GEB; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Canada; Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Canada., Trueman J; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada., Shaw K; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada., Staub M; Clinical Research Unit, Children's Hospital Research Institute of Manitoba, Canada., Chaudhry S; Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Canada., Miao F; British Columbia Children's Hospital Research Institute, Canada., Higginson M; British Columbia Children's Hospital Research Institute, Canada., Groeneweg GSS; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada., Brown J; British Columbia Women's Hospital and Health Centre, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada., Magee LA; School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College, UK., Whyte SD; British Columbia Children's Hospital Research Institute, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada; Department of Pediatric Anesthesia, British Columbia Children's Hospital, Canada., West N; British Columbia Children's Hospital Research Institute, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada; Department of Pediatric Anesthesia, British Columbia Children's Hospital, Canada., Brodie SM; British Columbia Children's Hospital Research Institute, Canada; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Canada., Jong G'; Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Canada; Clinical Research Unit, Children's Hospital Research Institute of Manitoba, Canada; Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Canada., Israels S; Department of Pediatrics and Child Health, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Canada., Berger H; Department of Obstetrics and Gynecology, St. Michael's Hospital, Canada; Epi Methods Consulting, Canada., Ito S; Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Canada., Rassekh SR; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada; Division of Pediatric Hematology/Oncology/BMT, Department of Pediatrics, Children's Heart Centre, BC Children's Hospital, University of British Columbia, Canada., Sanatani S; Division of Cardiology, Department of Pediatrics, Children's Heart Centre, BC Children's Hospital, University of British Columbia, Canada., Ross CJD; Faculty of Pharmaceutical Sciences, University of British Columbia, Canada; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada., Carleton BC; Faculty of Pharmaceutical Sciences, University of British Columbia, Canada; British Columbia Children's Hospital Research Institute, Canada; Pharmaceutical Outcomes Programme, British Columbia Children's Hospital, Canada; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Canada. Electronic address: bcarleton@popi.ubc.ca.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Apr; Vol. 148, pp. 112684. Date of Electronic Publication: 2022 Feb 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Antiemetics*/adverse effects , Ondansetron*/adverse effects, Child ; Female ; Genome-Wide Association Study ; Humans ; Nausea/chemically induced ; Nausea/drug therapy ; Pregnancy ; Pregnant Women

المؤلفون: Lin JJ; Department of Medical Genetics, University of British Columbia, Vancouver, Canada; BC Children's Hospital Research Institute, Vancouver, Canada; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, Canada., Loucks CM; BC Children's Hospital Research Institute, Vancouver, Canada; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, Canada., Trueman JN; BC Children's Hospital Research Institute, Vancouver, Canada; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, Canada., Drögemöller BI; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada., Wright GEB; Department of Pharmacy and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada., Yoshida EM; Division of Gastroenterology, University of British Columbia, Vancouver, Canada., Ford JA; Division of Gastroenterology, University of British Columbia, Vancouver, Canada., Lee SS; Liver Unit, University of Calgary Cumming School of Medicine, Calgary, Canada., Kim RB; Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada., Al-Judaibi B; Division of Transplantation, University of Rochester, Rochester, United States; Department of Liver Transplantation and Hepatobiliary Surgery, King Faisal Special Hospital and Research Center, Saudi Arabia., Schwarz UI; Division of Clinical Pharmacology, Department of Medicine, Western University, London, Canada., Ramji A; Division of Gastroenterology, University of British Columbia, Vancouver, Canada; Pacific Gastroenterology Associates, Vancouver, Canada., Tam E; LAIR Centre, Vancouver, Canada., Ross CJ; Department of Medical Genetics, University of British Columbia, Vancouver, Canada; BC Children's Hospital Research Institute, Vancouver, Canada; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada., Carleton BC; Department of Medical Genetics, University of British Columbia, Vancouver, Canada; BC Children's Hospital Research Institute, Vancouver, Canada; Division of Translational Therapeutics, Department of Pediatrics, University of British Columbia, Vancouver, Canada; Pharmaceutical Outcomes Program, British Columbia Children's Hospital, Vancouver, Canada. Electronic address: bcarleton@popi.ubc.ca.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2021 Nov; Vol. 143, pp. 112195. Date of Electronic Publication: 2021 Sep 22.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacogenomic Variants*, Anemia, Hemolytic/*chemically induced , Antiviral Agents/*adverse effects , Glycophorins/*genetics , Hepatitis C, Chronic/*drug therapy , Ribavirin/*adverse effects, Aged ; Anemia, Hemolytic/diagnosis ; Anemia, Hemolytic/genetics ; Canada ; Case-Control Studies ; Female ; Genome-Wide Association Study ; Hepatitis C, Chronic/diagnosis ; Humans ; Male ; Middle Aged ; Pharmacogenetics ; Pharmacogenomic Testing ; Prospective Studies ; Pyrophosphatases/genetics ; Receptors, Calcitriol/genetics ; Risk Assessment ; Risk Factors